glp-1-directed nmda receptor antagonism for obesity treatment New Developments in Pharmacological of and Type 2 Diabetes—Beyond and within GLP-1 Agonists Oral GLP-1-Based Therapeutics in the

an augmented insulin response to an oral glucose load compared with intravenous (IV) glucose administration

We believe that significant efforts should be put into investigating in greater detail the pathways shared by eryptosis and erythronecroptosis, like caspase-8, ROS signaling, Fas/FasL signaling, to collect more evidence on the interplay between these erythrocyte-specific RCDs

In this systematic review, the authors conducted a comprehensive analysis of clinical trials to determine the impact of GLP-1 receptor agonists in reducing substance use disorder in patients

How much water should I drink on tirzepatide to prevent UTIs

The cardiovascular safety profile appears favorable, with no increased risk of major adverse cardiac events in available data